New Assay To Detect Monkeypox Virus CerTest VIASURE Now Commercially Available Globally

BD (Becton, Dickinson and Company) (BDX), and CerTest Biotec on Monday said their new assay to detect monkeypox virus, CerTest VIASURE, is now commercially available globally, including in the United States, only for research use.

The BD MAX System family is an automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours. BD's proprietary BD MAX System open architecture reagent suite has been used to develop the CerTest VIASURE.

BD said it plans to submit a clinical test for monkeypox virus for emergency use authorization (EUA) as soon as possible, based on the guidance issued by the FDA on September 7.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT